Category Archives: Pharmacogenomics

Session 6: Genomics in Patients with Hispanic ancestry
Session 6: Pharmacogenomics in the global landscape: Pharmacogenetics and Ethnicity Speaker: Adrian Llerena, CHMP-Pharmacogenomics Working Party member Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:0 0ratingsTime:26:36More inScience Technology

Follow this link:
Session 6: Genomics in Patients with Hispanic ancestry - Video

Session 2: Panel discussion (Q A and Discussion)
Session 2: Methodology and adaptive designs and in confirmatory clinical trials Discussants: Emmanuel Zuber, Mathias Chiano, Marie Watissee Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:2 0ratingsTime:26:39More inScience Technology

Original post:
Session 2: Panel discussion (Q

Session 4: Pharmacogenomics: a long(er) learning curve? Opening keynote lecture
Session 4: Pharmacogenomics guided treatments in clinical care: experience from patients and health care professionals (HCPs) Speaker: Hans Georg-Eichler, Senior Medical Officer, EMA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:4 0ratingsTime:19:01More inScience Technology

Read more from the original source:
Session 4: Pharmacogenomics: a long(er) learning curve? Opening keynote lecture - Video

Session 4: Pharmacogenomics guided treatments in clinical care: experience from...
...patients and health care professionals (HCPs) Speaker: David Haerry, EATG, Belgium Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:7 0ratingsTime:14:30More inScience Technology

View post:
Session 4: Pharmacogenomics guided treatments in clinical care: experience from... - Video

Session 1: Panel discussion
Session 1: Pharmacogenomics: regulatory and methodological implications in early clinical development Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:1 0ratingsTime:18:55More inScience Technology

Original post:
Session 1: Panel discussion - Video

Pharmacogenomics in Rare Diseases: Development Strategy for Ivacaftor...
...as a Therapy for Cystic Fibrosis Session 1: Pharmacogenomics: regulatory and methodological implications in early clinical development Speaker: Federico Goodsaid, Vertex Pharmaceuticals, USA Workshop on Pharmacogenomics: from science to clinical care (8 October 2012)From:emainfoViews:1 0ratingsTime:32:26More inScience Technology

See the original post:
Pharmacogenomics in Rare Diseases: Development Strategy for Ivacaftor... - Video